H Xin, C Zhang, A Herrmann, Y Du, R Figlin, H Yu - Cancer research, 2009 - AACR
The novel multitargeted tyrosine kinase inhibitor sunitinib is used as an antiangiogenic
agent for the treatment of several types of cancer, including metastatic renal cell carcinoma …